Persephone Biosciences

📍 San Diego, United States🗓 Founded 2017👥 18 employees💰 Last funded Aug 2023
Biotechnology Research🌐 persephonebiosciences.com
Website LinkedIn
Persephone is pioneering the use of synthetic biology for microbial products that impact patient and infant health. We are building an end-to-end platform to industrialize the development of engineered cells that restore health to damaged human ecosystems. The company was founded in the summer of 2017 by synthetic and metabolic engineering pioneers, Stephanie Culler PhD, and Steve Van Dien PhD.
4
Total investors
2
Early stage
0
Mid stage
2
Late stage
2017
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
4
Investor activity2017–2023 · investors recorded per year
201712019120232
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Persephone Biosciences?
Persephone Biosciences has 4 investors on record on gritt.io, including 2 early-stage backers and 2 late-stage investors.
When did Persephone Biosciences last raise funding?
The most recent investment in Persephone Biosciences recorded on gritt.io was in August 2023.
When was Persephone Biosciences founded?
Persephone Biosciences was founded in 2017.
What industry is Persephone Biosciences in?
Persephone Biosciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Persephone Biosciences based?
Persephone Biosciences is headquartered in San Diego, United States.